Cytek Biosciences (CTKB) Financials: Revenue & Earnings
CTKB$6.01+0.04 +0.59%
$781.85M
Market Cap
—
P/E
—
Forward P/E
—
Score
Cytek Biosciences (CTKB) Financials: Revenue & Earnings
CTKB price $6.01 +0.04 +0.59%
- Ticker
- CTKB
- Price
- $6.01
- Change
- +0.04 +0.59%
- Market cap ?
- $781.85M
- Beta ?
- 1.16
- Sector
- Healthcare
- Industry
- Medical - Devices
Fair value
CTKB fair value $2.22. Price $6.01. Price is 171% above fair value.
Above fair value, and more expensive than usual. A larger premium than on more than 99% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 29.54M. Growth 3.82%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.68% (beta 1.2). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 129.98M. Net debt -67.11M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | -0.07 | — | 53.05M |
| 2026-08-05 | -0.05 | -0.09 | 48.14M | 47.31M |
| 2026-05-07 | -0.12 | -0.08 | 44.13M | 44.23M |
| 2026-02-26 | -0.34 | -0.02 | 62.14M | 57.15M |
| 2025-11-05 | -0.01 | -0.03 | 52.29M | 51.21M |
| 2025-08-06 | -0.04 | -0.02 | 45.60M | 46.34M |
| 2025-05-08 | -0.09 | -0.04 | 41.46M | 42.66M |
| 2025-02-27 | 0.07 | 0.05 | 57.48M | 59.38M |
| 2024-11-05 | 0.01 | -0.01 | 51.50M | 50.70M |
| 2024-08-06 | -0.08 | -0.03 | 46.62M | 49.53M |
| 2024-05-08 | -0.05 | -0.04 | 44.86M | 43.59M |
| 2024-02-28 | 0.07 | 0.03 | 58.60M | 56.58M |
| 2023-11-07 | 0.01 | 0.03 | 48.00M | 55.48M |
| 2023-08-08 | 0.01 | 0.03 | 49.69M | 45.71M |
| 2023-05-09 | -0.05 | 0.03 | 37.09M | 47.15M |
| 2023-02-28 | 0.06 | 0.05 | 48.30M | 50.22M |
| 2022-11-09 | 0.04 | 0.02 | 40.48M | 43.29M |
| 2022-08-10 | 0.03 | 0.02 | 40.16M | 39.63M |
| 2022-05-11 | 0.01 | 0.01 | 35.06M | 32.51M |
| 2022-02-23 | 0.05 | 0.03 | 38.90M | 36.42M |
| 2021-11-08 | 0.02 | 0.02 | 34.38M | 30.41M |
| 2021-09-02 | 0.02 | 0.02 | 30.41M | 28.27M |
| 2021-07-27 | 0.00 | — | 24.27M | — |
| 2020-12-31 | 0.05 | — | 30.62M | — |
| 2020-09-30 | 0.18 | — | 25.10M | — |
| 2020-06-30 | 0.23 | — | 19.14M | — |
| 2020-03-31 | -0.01 | — | 17.99M | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-18 | Jiang Wenbin | Buy | 57.21K | — | — |
| 2026-08-18 | Jiang Wenbin | Sell | 20.96K | $4.67 | 97.86K |
| 2026-08-18 | Jiang Wenbin | Buy | 29.00K | — | — |
| 2026-08-18 | Jiang Wenbin | Sell | 7.06K | $4.67 | 32.98K |
| 2026-08-18 | Jiang Wenbin | Buy | 22.10K | — | — |
| 2026-08-18 | Jiang Wenbin | Sell | 5.38K | $4.67 | 25.13K |
| 2026-08-18 | Jiang Wenbin | Buy | 11.78K | — | — |
| 2026-08-18 | Jiang Wenbin | Sell | 2.87K | $4.67 | 13.40K |
| 2026-08-18 | Jiang Wenbin | Sell | 57.21K | — | — |
| 2026-08-18 | Jiang Wenbin | Sell | 29.00K | — | — |
| 2026-08-18 | Jiang Wenbin | Sell | 22.10K | — | — |
| 2026-08-18 | Jiang Wenbin | Sell | 11.78K | — | — |
| 2026-08-18 | McCombe William D. | Sell | 16.05K | — | — |
| 2026-08-18 | McCombe William D. | Buy | 16.05K | — | — |
| 2026-08-18 | McCombe William D. | Sell | 13.05K | — | — |
| 2026-08-18 | McCombe William D. | Sell | 5.40K | $4.67 | 25.22K |
| 2026-08-18 | McCombe William D. | Buy | 13.05K | — | — |
| 2026-08-18 | McCombe William D. | Sell | 4.39K | $4.67 | 20.51K |
| 2026-08-18 | McCombe William D. | Buy | 6.32K | — | — |
| 2026-08-18 | McCombe William D. | Sell | 2.11K | $4.67 | 9.86K |
| 2026-08-18 | McCombe William D. | Sell | 6.32K | — | — |
| 2026-08-18 | MUIR GLENN P | Sell | 3.09K | — | — |
| 2026-08-18 | MUIR GLENN P | Buy | 3.09K | — | — |
| 2026-08-18 | Holder Michael | Buy | 2.18K | — | — |
| 2026-08-18 | Holder Michael | Sell | 2.18K | — | — |
| 2026-08-18 | Chin Richard | Sell | 6.11K | — | — |
| 2026-08-18 | Chin Richard | Buy | 6.11K | — | — |
| 2026-08-18 | Yan Ming | Buy | 14.22K | — | — |
| 2026-08-18 | Yan Ming | Sell | 3.46K | $4.67 | 16.17K |
| 2026-08-18 | Yan Ming | Buy | 6.16K | — | — |
| 2026-08-18 | Yan Ming | Sell | 1.50K | $4.67 | 7.01K |
| 2026-08-18 | Yan Ming | Buy | 5.53K | — | — |
| 2026-08-18 | Yan Ming | Sell | 1.35K | $4.67 | 6.29K |
| 2026-08-18 | Yan Ming | Buy | 7.36K | — | — |
| 2026-08-18 | Yan Ming | Sell | 1.78K | $4.67 | 8.30K |
| 2026-08-18 | Yan Ming | Sell | 14.22K | — | — |
| 2026-08-18 | Yan Ming | Sell | 6.16K | — | — |
| 2026-08-18 | Yan Ming | Sell | 5.53K | — | — |
| 2026-08-18 | Yan Ming | Sell | 7.36K | — | — |
| 2026-08-10 | Feuchtwang Ilan | Buy | 241.42K | — | — |
| 2026-08-10 | Feuchtwang Ilan | Buy | 127.12K | $4.66 | 592.37K |
| 2026-06-29 | Feuchtwang Ilan | Other | 0 | — | — |
| 2026-06-12 | Yan Ming | Sell | 135.89K | — | — |
| 2026-06-10 | Ball Jack | Buy | 43.97K | — | — |
| 2026-06-10 | Ball Jack | Sell | 43.97K | — | — |
| 2026-06-10 | MUIR GLENN P | Buy | 55.55K | — | — |
| 2026-06-10 | MUIR GLENN P | Buy | 29.84K | $4.05 | 120.83K |
| 2026-06-10 | MUIR GLENN P | Other | 0 | — | — |
| 2026-06-10 | Chin Richard | Buy | 33.33K | — | — |
| 2026-06-10 | Chin Richard | Buy | 18.26K | $4.05 | 73.96K |
| 2026-06-10 | Imper Vera | Buy | 43.97K | — | — |
| 2026-06-10 | Imper Vera | Buy | 33.33K | — | — |
| 2026-06-10 | Imper Vera | Buy | 18.26K | $4.05 | 73.96K |
| 2026-06-10 | Imper Vera | Sell | 43.97K | — | — |
| 2026-06-10 | NEFF DEBORAH J | Buy | 43.97K | — | — |
| 2026-06-10 | NEFF DEBORAH J | Buy | 33.33K | — | — |
| 2026-06-10 | NEFF DEBORAH J | Buy | 18.26K | $4.05 | 73.96K |
| 2026-06-10 | NEFF DEBORAH J | Sell | 43.97K | — | — |
| 2026-06-10 | Holder Michael | Buy | 43.97K | — | — |
| 2026-06-10 | Holder Michael | Buy | 33.33K | — | — |
| 2026-06-10 | Holder Michael | Buy | 18.26K | $4.05 | 73.96K |
| 2026-06-10 | Holder Michael | Sell | 43.97K | — | — |
| 2026-05-18 | Holder Michael | Buy | 1.45K | — | — |
| 2026-05-18 | Holder Michael | Sell | 1.45K | — | — |
| 2026-05-18 | Chin Richard | Sell | 6.11K | — | — |
| 2026-05-18 | Chin Richard | Buy | 6.11K | — | — |
| 2026-05-18 | Yan Ming | Buy | 9.48K | — | — |
| 2026-05-18 | Yan Ming | Sell | 2.36K | $3.55 | 8.39K |
| 2026-05-18 | Yan Ming | Buy | 4.11K | — | — |
| 2026-05-18 | Yan Ming | Sell | 1.02K | $3.55 | 3.64K |
| 2026-05-18 | Yan Ming | Buy | 3.68K | — | — |
| 2026-05-18 | Yan Ming | Sell | 919 | $3.55 | 3.26K |
| 2026-05-18 | Yan Ming | Buy | 4.91K | — | — |
| 2026-05-18 | Yan Ming | Sell | 1.22K | $3.55 | 4.35K |
| 2026-05-18 | Yan Ming | Sell | 9.48K | — | — |
| 2026-05-18 | Yan Ming | Sell | 4.11K | — | — |
| 2026-05-18 | Yan Ming | Sell | 3.68K | — | — |
| 2026-05-18 | Yan Ming | Sell | 4.91K | — | — |
| 2026-05-18 | Busque Philippe | Sell | 5.55K | — | — |
| 2026-05-18 | Busque Philippe | Buy | 5.55K | — | — |
| 2026-05-18 | Busque Philippe | Sell | 1.42K | $3.55 | 5.06K |
| 2026-05-18 | Busque Philippe | Sell | 2.42K | — | — |
| 2026-05-18 | Busque Philippe | Buy | 2.42K | — | — |
| 2026-05-18 | Busque Philippe | Sell | 620 | $3.55 | 2.20K |
| 2026-05-18 | Busque Philippe | Buy | 1.47K | — | — |
| 2026-05-18 | Busque Philippe | Sell | 378 | $3.55 | 1.34K |
| 2026-05-18 | Busque Philippe | Buy | 1.02K | — | — |
| 2026-05-18 | Busque Philippe | Sell | 263 | $3.55 | 934 |
| 2026-05-18 | Busque Philippe | Sell | 1.47K | — | — |
| 2026-05-18 | Busque Philippe | Sell | 1.02K | — | — |
| 2026-05-18 | Jiang Wenbin | Buy | 38.14K | — | — |
| 2026-05-18 | Jiang Wenbin | Sell | 15.01K | $3.55 | 53.28K |
| 2026-05-18 | Jiang Wenbin | Buy | 19.33K | — | — |
| 2026-05-18 | Jiang Wenbin | Sell | 5.03K | $3.55 | 17.86K |
| 2026-05-18 | Jiang Wenbin | Buy | 14.73K | — | — |
| 2026-05-18 | Jiang Wenbin | Sell | 3.59K | $3.55 | 12.74K |
| 2026-05-18 | Jiang Wenbin | Buy | 7.85K | — | — |
| 2026-05-18 | Jiang Wenbin | Sell | 1.91K | $3.55 | 6.79K |
| 2026-05-18 | Jiang Wenbin | Sell | 38.14K | — | — |
| 2026-05-18 | Jiang Wenbin | Sell | 19.33K | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 156, holders -9 vs prior quarter. Ownership 63.84%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 9.58M | -7.43M | -43.68% | 42.43M |
| MILLENNIUM MANAGEMENT LLC | 9.34M | 3.05M | +48.42% | 41.37M |
| BOSTON PARTNERS | 7.66M | 1.86M | +32.02% | 33.94M |
| HHLR ADVISORS, LTD. | 6.66M | 0 | 0.00% | 29.49M |
| TOPLINE CAPITAL MANAGEMENT, LLC | 6.28M | -781.03K | -11.06% | 27.84M |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.94M | 176.69K | +3.71% | 21.88M |
| GEODE CAPITAL MANAGEMENT, LLC | 3.06M | 225.62K | +7.96% | 13.56M |
| DIMENSIONAL FUND ADVISORS LP | 2.62M | -47.07K | -1.77% | 11.59M |
| STATE STREET CORP | 2.57M | -1.56M | -37.77% | 11.37M |
| GOLDMAN SACHS GROUP INC | 2.17M | -177.22K | -7.56% | 9.60M |
| ROYCE & ASSOCIATES LP | 2.08M | 439.21K | +26.74% | 9.22M |
| RUSSELL INVESTMENTS GROUP, LTD. | 1.51M | 151.41K | +11.13% | 6.70M |
| ACADIAN ASSET MANAGEMENT LLC | 1.38M | 977.06K | +244.88% | 6.09M |
| BANK OF AMERICA CORP /DE/ | 1.32M | 306.28K | +30.35% | 5.83M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.14M | -1.17M | -50.62% | 5.06M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.07M | -31.35K | -2.84% | 4.75M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 1.07M | 1.07M | New | 4.75M |
| NORTHERN TRUST CORP | 1.00M | -1.90K | -0.19% | 4.44M |
| HRT FINANCIAL LP | 997.77K | 583.72K | +140.98% | 4.42M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 973.83K | 653.92K | +204.41% | 4.31M |
| JANE STREET GROUP, LLC | 906.16K | 906.16K | New | 4.01M |
| TUDOR INVESTMENT CORP ET AL | 837.91K | 517.20K | +161.26% | 3.71M |
| AQR CAPITAL MANAGEMENT LLC | 813.97K | -98.37K | -10.78% | 3.61M |
| VANGUARD FIDUCIARY TRUST CO | 740.66K | 23.65K | +3.30% | 3.28M |
| CITADEL ADVISORS LLC | 721.47K | 250.08K | +53.05% | 3.20M |
Earnings and financials
Cytek Biosciences, Inc. (CTKB) trades at $6.01, with a market cap of $781.85M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn